Bristol Sells Its Mead Johnson Adult Nutritionals Business To Novartis
This article was originally published in The Tan Sheet
Executive Summary
The divestiture of Mead Johnson's adult nutritionals business to Novartis Medical Nutrition will allow the Bristol-Myers Squibb division to concentrate on its infant formula franchise
You may also be interested in...
Bristol-Myers Squibb Weighs Options On Mead Johnson
Bristol-Myers Squibb could reap as much as $10 billion by selling its Mead Johnson nutritional business and other non-pharmaceutical units, analysts say
Bristol-Myers Squibb Weighs Options On Mead Johnson
Bristol-Myers Squibb could reap as much as $10 billion by selling its Mead Johnson nutritional business and other non-pharmaceutical units, analysts say
Bristol-Myers Squibb Weighs Options On Mead Johnson
Bristol-Myers Squibb could reap as much as $10 billion by selling its Mead Johnson nutritional business and other non-pharmaceutical units, analysts say